Corrigendum to "Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV." Kidney International 2024;106:136-144.

Autor: Pelchen-Matthews A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK., Mocroft A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Ryom L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases 144, Hvidovre University Hospital, Copenhagen, Denmark., Ross MJ; Department of Medicine, Division of Nephrology, Albert Einstein College of Medicine, Bronx, New York, USA., Sharma S; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Coca S; Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Achhra A; Department of Medicine, Division of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, USA., Cornell E; Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, USA., Tracy R; Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, USA., Phillips A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK., Alonso MM; Infectious Diseases Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Toulomi G; Department of Hygiene, Epidemiology & Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Agan BK; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA., Medland N; Kirby Institute, University of New South Wales, Sydney, Australia., Wyatt CM; Department of Medicine, Division of Nephrology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: christina.wyatt@duke.edu.

Publikováno v: Kidney international [Kidney Int] 2024 Dec; Vol. 106 (6), pp. 1196.

Risk of Suicidal Behavior With Use of Efavirenz : Results from the Strategic Timing of Antiretroviral Treatment Trial

Autor: INSIGHT START study group, Arenas-Pinto, Alejandro, Grund, Birgit, Sharma, Shweta, Martinez, Esteban, Cummins, Nathan, Fox, Julie, Klingman, Karin L., Sedlacek, Dalibor, Collins, Simon, Flynn, Patricia M., Chasanov, William M., Kedem, Eynat, Katlama, Christine, Sierra-Madero, Juan, Afonso, Claudia, Brouwers, Pim, Cooper, David A.

Publikováno v: Clinical Infectious Diseases, 2018 Aug 01. 67(3), 420-429.

Externí odkaz: https://www.jstor.org/stable/26526361

Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort.

Autor: Zucco AG; PERSIMUNE Center of Excellence, Rigshospitalet., Bennedbæk M; Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut., Ekenberg C; PERSIMUNE Center of Excellence, Rigshospitalet., Gabrielaite M; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Leung P; PERSIMUNE Center of Excellence, Rigshospitalet., Polizzotto MN; Clinical Hub for Interventional Research, College of Health and Medicine, The Australian National University, Canberra, Australia., Kan V; George Washington University, Veterans Affairs Medical Center, Washington, DC, USA., Murray DD; PERSIMUNE Center of Excellence, Rigshospitalet., Lundgren JD; PERSIMUNE Center of Excellence, Rigshospitalet., MacPherson CR; PERSIMUNE Center of Excellence, Rigshospitalet.

Publikováno v: AIDS (London, England) [AIDS] 2023 Sep 01; Vol. 37 (11), pp. 1643-1650. Date of Electronic Publication: 2023 Apr 03.

Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.

Autor: Cozzi-Lepri A; Institute for Global Health, UCL, London, UK., Dunn D; Institute for Global Health, UCL, London, UK., Tostevin A; Institute for Global Health, UCL, London, UK., Marvig RL; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Bennedbaek M; Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institute, Copenhagen, Denmark., Sharma S; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Kozal MJ; Stanford University, Palo Alto, California, USA., Gompels M; North Bristol NHS Trust, Bristol, UK., Pinto AN; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Lundgren J; Copenhagen HIV Programme, Rigs Hospitalet, University of Copenhagen, Copenhagen, Denmark., Baxter JD; Cooper Medical School of Rowan University and Cooper University Health Care, Camden, New Jersey, USA.

Publikováno v: HIV medicine [HIV Med] 2024 Feb; Vol. 25 (2), pp. 212-222. Date of Electronic Publication: 2023 Sep 29.

Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.

Autor: for the INSIGHT START Study Group, Schlusser, Katherine E., Laeyendecker, Oliver, Sharma, Shweta, Neaton, James D., de la Torre, Pola, Tambussi, Giuseppe, Draenert, Rika, Pinto, Angie N., Metcalf, Julia A., German, Danielle

Publikováno v: AIDS & Behavior; Jul2018, Vol. 22 Issue 7, p2277-2283, 7p, 3 Charts